SCHEMBL1428409

SCHEMBL1428409

CC(C)(C)OC(=O)NCCCC[C@@H](CNC(=O)c1nc(Cl)c(N)nc1N)NC(=O)CCc1ccc(OCc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.54
MAPT P10636 3/20 0.41
PSMB5 P28074 3/20 0.41
PSMB8 P28062 1/20 0.41
PSMB9 P28065 1/20 0.41
HDAC1 Q13547 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.39
PSMB1 P20618 2/20 0.39
PSMB2 P49721 2/20 0.39
PAX8 Q06710 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SCNN1A P37088 2/20 0.39
ITGB3 P05106 1/20 0.39
ITGA2B P08514 1/20 0.39
POLB P06746 1/20 0.39
MAPK1 P28482 1/20 0.39
LTA4H P09960 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1428391 0.94 KCNH2 (0.56) KCNH2MAPTPSMB5PSMB8PSMB9
SCHEMBL1134630 0.94 KCNH2 (0.62) KCNH2MAPTPSMB5PSMB8PSMB9
SCHEMBL1134515 0.89 KCNH2 (0.65) KCNH2MAPTPSMB5PSMB8PSMB9
SCHEMBL1134587 0.85 SYK (0.53) KCNH2MAPTL3MBTL1PAX8TDP1
SCHEMBL1134585 0.84 MAPT (0.56) KCNH2MAPTL3MBTL1PAX8TDP1
SCHEMBL11980209 0.83 KCNH2 (0.62) KCNH2SCNN1ALTA4H
SCHEMBL2075136 0.83 KCNH2 (0.61) KCNH2SCNN1ALTA4H
Hydrochloric Acid SCHEMBL1134542 0.82 KCNH2 (0.60) KCNH2SCNN1ALTA4H
SCHEMBL11959314 0.81 KCNH2 (0.64) KCNH2SCNN1ALTA4H
Iodide SCHEMBL1428394 0.81 KCNH2 (0.63) KCNH2SCNN1ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300010-A2 ORGANIC COMPOUNDS Novartis AG (CH) 2011-03-30 EP disclosed
WO-2009150137-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-17 WO disclosed